|
Recruiting
|
NCT05002270 -
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT04981119 -
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
|
|
|
Active, not recruiting
|
NCT01308086 -
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
|
Phase 3 |
|
Active, not recruiting
|
NCT04585035 -
Study to Evaluate D-1553 in Subjects With Solid Tumors
|
Phase 1/Phase 2 |
|
Completed
|
NCT03665285 -
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 |
|
Active, not recruiting
|
NCT03336658 -
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
|
|
|
Recruiting
|
NCT06445062 -
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
|
Phase 1/Phase 2 |
|
Terminated
|
NCT03875313 -
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT05382377 -
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
|
Early Phase 1 |
|
Active, not recruiting
|
NCT05314309 -
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
|
|
|
Recruiting
|
NCT06259552 -
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
|
Phase 1 |
|
Completed
|
NCT05976282 -
Addressing Colorectal Cancer in South Florida Firefighters
|
N/A |
|
Recruiting
|
NCT01593098 -
A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)
|
|
|
Recruiting
|
NCT03597581 -
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
|
Phase 1 |
|
Terminated
|
NCT05368688 -
Microbiome in Colorectal Cancer Onset and Progression
|
|
|
Completed
|
NCT03965845 -
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
|
Phase 1/Phase 2 |
|
Not yet recruiting
|
NCT03601598 -
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT05009329 -
FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China
|
Phase 1/Phase 2 |
|
Completed
|
NCT02161549 -
Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy
|
N/A |